July 2021

Business Lawyer William Fish: Now’s Time to Acquire Businesses in Financial Distress, Especially in Senior-Housing Sector

In a recent Connecticut Law Tribune article, Partner William Fish Jr. described seeing a changing landscape due to the global pandemic that includes representing individuals and entities looking to acquire distressed businesses.“In terms of opportunities…

June 2021

CARES Act Provider Relief Fund Enforcement Actions on the Rise

In May of 2021, the United States Department of Health and Human Services (“HHS”) announced a sweeping audit of certain health care providers who received general distribution payments from the Provider Relief Fund. As a result, 2021 may see an increas…

Timing is Everything: A Conversation with Jared L. Shwartz

Jared L. Shwartz is an associate at Hinckley Allen’s Boston office. He advises businesses on a wide variety of matters, including governance, entity choice and formation, mergers and acquisitions, contract and financing negotiations, and related transact…

September 2019

The Medicare Home Health Patient Driven Grouping Model: New Requirements for Home Health Care

The Medicare Home Health Patient Driven Grouping Model (PDGM), the most significant change to how agencies are reimbursed for home health services in 20 years, takes effect on January 1, 2020. Predicting the financial impact in transitioning to this new mo…

May 2019

Tips for Recreational Marijuana Use Policies in “Social Model” Assisted Living Residences

As more states consider legalizing recreational marijuana, assisted living residences (ALRs) face a unique challenge: residents that chose to use this product.  Formal guidance regarding how ALRs should address a resident’s use of recreational marijuana…

February 2019

Doctor Who Gave Drug Representative Electronic Medical Record Access Begins Probation & Expresses Remorse for Criminal Act

Laura B. Angelini provides her insights in a recent article about a recent case regarding the False Claims Act, where a doctor violated HIPAA upon sharing protected health information with a representative from a pharmaceuticals company.